50 years of Wellness Solutions
Neptune was founded in 1998. Initially, our main goal was to bring to market a novel source of omega-3 phospholipids. We accomplished this milestone when we pioneered the krill oil industry with our flagship product, Neptune Krill Oil (NKO®) in 2003. Utilizing a proprietary extraction process, we successfully developed a superior marine Omega-3 product.
On January 7, 2016, Neptune announced its acquisition of Montreal-based, privately held Biodroga. Biodroga is a leading turnkey solution provider of Omega-3s and other functional ingredients to branded marketers in the nutraceutical industry. Their customized product offerings include primarily Omega-3s, along with other essential nutritional ingredients used in specialty formulations.
In July 2016, Neptune unveiled its new positioning and corporate identity, Neptune Wellness Solutions, which incorporates both companies and adds up to close to 50 years of experience in wellness solutions.
Leveraging its extensive experience in the extraction and commercialization of novel health products, Neptune submitted an application to Health Canada to become a licensed processor of cannabis and hemp oil in April 2017.
In May 2017, the company announced its participation in the creation of the Sherbrooke-based Green Valley Consortium, a strategic partnership of industry and academic stakeholders aimed to facilitate production, research and development of cannabis and cannabis-related initiatives in the region.
In August 2017, Neptune exits bulk krill oil manufacturing by announcing that they have concluded an agreement with Aker BioMarine. As an innovator in the krill oil omega-3 phospholipid market, Neptune continues to be committed to this segment. The company will continue to offer krill oil in softgels via its solutions business in collaboration with Aker.
In November 2017, the company announced capital expenditures of $5 million to make its GMP certified Sherbrooke facility ready and compliant for the extraction of cannabis and hemp oil.
On June 5th 2018 Neptune announced a $4.8 million investment for solvent extraction and purification for the phase 2 expansion at its Sherbrooke facility.
On September 14th 2018, Neptune received a Confirmation of Readiness letter from Health Canada in regard to its application to become a Licensed Processor under the Cannabis Act and its Regulations.
On December 21st, 2018, the company entered into a multi-year IP licencing and capsule sale agreement with Lonza a global leader in the life sciences industry.
On January 4th, 2019, Neptune’s wholly owned subsidiary, 9354-7537 Québec Inc., received its licence from Health Canada to process cannabis.
Read all about our products.